Issue Date: February 24, 2014
FDA Head Voices Concerns In India
During a one-week visit to India, the second-largest foreign supplier of pharmaceuticals to the U.S., FDA Commissioner Margaret A. Hamburg warned pharma executives there that she will not tolerate lapses in drug quality.
“In recent years, FDA has identified significant lapses in quality by some companies operating in the U.S. and around the world,” Hamburg noted in a blog entry made during her trip, which concluded last week. Her message to Indian . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society